ROLE OF SIRT1 AND AMPK IN THE DEVELOPMENT OF INSULIN RESISTANCE ASSOCIATED TO NON-ALCOHOLIC FATTY LIVER DISEASE

被引：0
|
作者：
Silvestre, M. [1 ]
Sugden, M. [1 ]
Viollet, B. [2 ]
Holness, M. [1 ]
机构：
[1] Queen Mary Univ London, BICMS, Ctr Diabet, London, England
[2] Inst Cochin, Dept Endocrinol Metab & Canc, Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)61274-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1262
引用
收藏
页码：S499 / S499
页数：1
相关论文
共 50 条
  • [1] Role of the AMPK/SIRT1 pathway in non-alcoholic fatty liver disease (Review)
    Anggreini, Putri
    Kuncoro, Hadi
    Sumiwi, Sri Adi
    Levita, Jutti
    MOLECULAR MEDICINE REPORTS, 2023, 27 (02)
  • [2] A Potential Treatment of Non-Alcoholic Fatty Liver Disease with SIRT1 Activators
    Colak, Yasar
    Yesil, Atakan
    Mutlu, Hasan Huseyin
    Caklili, Ozge Telci
    Ulasoglu, Celal
    Senates, Ebubekir
    Takir, Mumtaz
    Kostek, Osman
    Yilmaz, Yusuf
    Enc, Feruze Yilmaz
    Tasan, Guralp
    Tuncer, Ilyas
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2014, 23 (03) : 311 - 319
  • [3] Role of cytokines and insulin resistance in non-alcoholic fatty liver disease
    Das, S. K.
    Mukherjee, S.
    Pandey, G.
    Varadhan, S.
    Dhanya, L.
    Balakrishnan, V.
    Vasudevan, D. M.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A111 - A112
  • [4] Non-alcoholic fatty liver disease and insulin resistance
    Machado, M
    Cortez-Pinto, H
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (08) : 823 - 826
  • [5] Therapeutic effects of isosteviol sodium on non-alcoholic fatty liver disease by regulating autophagy via Sirt1/AMPK pathway
    Ying Mei
    Hui Hu
    Liangjun Deng
    Xiaoou Sun
    Wen Tan
    Scientific Reports, 12
  • [6] Therapeutic effects of isosteviol sodium on non-alcoholic fatty liver disease by regulating autophagy via Sirt1/AMPK pathway
    Mei, Ying
    Hu, Hui
    Deng, Liangjun
    Sun, Xiaoou
    Tan, Wen
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [7] 11β-HSD1 Inhibitor Alleviates Non-Alcoholic Fatty Liver Disease by Activating the AMPK/SIRT1 Signaling Pathway
    Chen, Ying
    Li, Jiali
    Zhang, Meng
    Yang, Wei
    Qin, Wenqi
    Zheng, Qinzhou
    Chu, Yanhui
    Wu, Yan
    Wu, Dan
    Yuan, Xiaohuan
    NUTRIENTS, 2022, 14 (11)
  • [8] Silibinin Restores NAD+ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
    Salomone, Federico
    Barbagallo, Ignazio
    Godos, Justyna
    Lembo, Vincenzo
    Currenti, Walter
    Cina, Diana
    Avola, Roberto
    D'Orazio, Nicolantonio
    Morisco, Filomena
    Galvano, Fabio
    Li Volti, Giovanni
    NUTRIENTS, 2017, 9 (10):
  • [9] Insulin resistance, inflammation, and non-alcoholic fatty liver disease
    Tilg, Herbert
    Moschen, Alexander R.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2008, 19 (10): : 371 - 379
  • [10] ASSOCIATION OF INSULIN RESISTANCE AND NON-ALCOHOLIC FATTY LIVER DISEASE
    Mishina, Ekaterina E.
    Mayorov, Alexander Y.
    Bogomolov, Pavel O.
    Liusina, Ekaterina O.
    Bueverov, Alexey O.
    DIABETES MELLITUS, 2020, 23 (05): : 412 - 423
12345